Company · CIK 0001604821 · SIC 8071 — Services-Medical Laboratories · Nasdaq
Natera, Inc. · NTRA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 SForm 4 → | Sep 25, 9:35 pm EDT | Jonathan SheenaDirector | 18,064 | $388.01 | $7,008,972 | 9,000 | −66.7% | 10b5-1 |
| Sep 16, 2026 GForm 4 → | Sep 18, 9:35 pm EDT | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | 945 | — | — | 109,914 | — | |
| Sep 15, 2026 SForm 4 → | Sep 17, 9:35 pm EDT | Jonathan SheenaDirector | 9,150 | $351.49 | $3,216,145 | 221,314 | −3.97% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 16, 9:35 pm EDT | Matthew RabinowitzEXECUTIVE CHAIRMAN, Director | 102,000 | $341.15 | $34,797,271 | 0 | −100% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 11, 9:35 pm EDT | Matthew RabinowitzEXECUTIVE CHAIRMAN, Director | 50,000 | $327.97 | $16,398,267 | 2,225,394 | −2.20% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 9:35 pm EDT | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | 18,160 | $325.88 | $5,917,907 | 110,859 | −14.1% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 9:05 pm EDT | Steven Leonard ChapmanCEO AND PRESIDENT, Director | 1,698 | $320.99 | $545,041 | 98,199 | −1.70% | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 28, 9:35 pm EDT | John FeskoPRESIDENT, CHIEF BUS. OFFICER | 6,517 | $321.53 | $2,095,411 | 197,257 | −3.20% | 10b5-1 late |
| Aug 10, 2026 SForm 4 → | Aug 14, 9:35 pm EDT | Jonathan SheenaDirector | 6,000 | $325.32 | $1,951,942 | 230,464 | −2.54% | 10b5-1 late |
| Aug 7, 2026 SForm 4 → | Aug 7, 9:35 pm EDT | Matthew RabinowitzEXECUTIVE CHAIRMAN, Director | 2,000 | $320.90 | $641,800 | 2,000 | −50.0% | 10b5-1 |
| Aug 7, 2026 SForm 4 → | Aug 7, 9:35 pm EDT | Jonathan SheenaDirector | 9,150 | $315.66 | $2,888,325 | 236,464 | −3.73% | 10b5-1 |
| Aug 6, 2026 AForm 4 → | Aug 28, 9:35 pm EDT | John FeskoPRESIDENT, CHIEF BUS. OFFICER | 20,000 | — | — | 203,774 | — | 10b5-1 late |
| Aug 3, 2026 SForm 4 → | Aug 5, 9:35 pm EDT | Michael Burkes BrophyCHIEF FINANCIAL OFFICER | 795 | $271.74 | $216,030 | 51,637 | −1.52% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 9:35 pm EDT | Steven Leonard ChapmanCEO AND PRESIDENT, Director | 3,076 | $266.39 | $819,431 | 99,897 | −2.99% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 9:35 pm EDT | John FeskoPRESIDENT, CHIEF BUS. OFFICER | 295 | $267.99 | $79,057 | 183,774 | −0.16% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 9:35 pm EDT | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | 3,410 | $265.58 | $905,627 | 129,019 | −2.57% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 9:35 pm EDT | Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER | 334 | $267.99 | $89,508 | 170,073 | −0.20% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 9:35 pm EDT | Matthew RabinowitzEXECUTIVE CHAIRMAN, Director | 731 | $267.99 | $195,900 | 2,275,394 | −0.03% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 9:35 pm EDT | Jonathan SheenaDirector | 109 | $267.99 | $29,211 | 245,614 | −0.04% | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 29, 9:35 pm EDT | Jonathan SheenaDirector | 479 | $257.93 | $123,549 | 245,723 | −0.19% | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 29, 9:35 pm EDT | Matthew RabinowitzEXECUTIVE CHAIRMAN, Director | 1,718 | $260.49 | $447,523 | 2,276,125 | −0.08% | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 29, 9:35 pm EDT | Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER | 1,887 | $257.08 | $485,106 | 170,407 | −1.10% | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 29, 9:35 pm EDT | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | 2,214 | $257.00 | $568,997 | 132,429 | −1.64% | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 29, 9:35 pm EDT | John FeskoPRESIDENT, CHIEF BUS. OFFICER | 1,713 | $257.00 | $440,243 | 184,069 | −0.92% | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 29, 9:35 pm EDT | Steven Leonard ChapmanCEO AND PRESIDENT, Director | 5,770 | $256.51 | $1,480,047 | 102,973 | −5.31% | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 29, 9:35 pm EDT | Michael Burkes BrophyCHIEF FINANCIAL OFFICER | 5,064 | $253.28 | $1,282,634 | 52,432 | −8.81% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 17, 9:05 pm EDT | Jonathan SheenaDirector | 1,500 | $273.88 | $410,825 | 18,032 | −7.68% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 17, 9:05 pm EDT | Rowan E ChapmanDirector | 135 | $274.82 | $37,101 | 4,663 | −2.81% | 10b5-1 |
| Jul 13, 2026 SForm 4 → | Jul 15, 9:05 pm EDT | Jonathan SheenaDirector | 3,150 | $265.68 | $836,898 | 246,202 | −1.26% | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 9:05 pm EDT | Matthew RabinowitzEXECUTIVE CHAIRMAN, Director | 1,000 | $280.00 | $280,000 | 4,000 | −20.0% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 9:05 pm EDT | Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER | 16,800 | $272.29 | $4,574,431 | 172,294 | −8.88% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 9:05 pm EDT | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $272.90 | $818,711 | 134,643 | −2.18% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.